Literature DB >> 25923367

Change in corneal hysteresis over time in normal, glaucomatous and diabetic eyes.

Syed Amal Hussnain1, Joseph B Alsberge1, Joshua R Ehrlich1, Mitsugu Shimmyo2, Nathan M Radcliffe1.   

Abstract

PURPOSE: Corneal hysteresis (CH) is lower in glaucomatous eyes. The aim of this study was to determine and compare the change in CH over time between normal, open angle glaucoma (POAG) and diabetic subjects.
METHODS: We retrospectively analysed records of patients undergoing assessment with the Ocular Response Analyzer (Reichert, Corp., New York, NY, USA). Right eyes with at least 7 measurements were included. Patients with ocular pathology other than POAG were excluded. Two-sample t-tests, chi-squared and logistic regression were used to analyse data.
RESULTS: A total of 1418 normal and 322 POAG patients were included. Patients with POAG were significantly older (70.73 ± 11.33 vs. 61.59 ± 16.56 years; p < 0.001), had a longer follow-up (4.14 ± 1.34 vs. 2.72 ± 1.49 years; p < 0.001) and had lower CH (9.58 ± 2.17 vs. 9.95 ± 2.19 mmHg p = 0.01), but there were no gender differences between groups (61.5 vs. 57.7% female; p = 0.21). We observed a significantly greater decrease in CH among patients with POAG (-0.11 ± 0.73 vs. 0.07 ± 2.31 mm Hg/year; p = 0.02). The relation between ∆CH/year and diagnosis persisted after adjusting for age and follow-up time (OR 0.90; 95% CI 0.82, 0.99; p = 0.03). We found CH to be higher in diabetics vs. non-diabetics (10.34 ± 2.04 vs. 9.88 ± 2.19; p = 0.02), but ∆CH/year was not different (0.07 ± 1.27 vs. 0.03 ± 2.10; p = 0.77).
CONCLUSIONS: Patients with POAG in this study had a significantly greater rate of CH decline compared to normal. There was no significant difference in rate of CH change in diabetic and non-diabetic patients.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  change over time; corneal hysteresis; ocular response analyser; open angle glaucoma; type 2 diabetes

Mesh:

Year:  2015        PMID: 25923367     DOI: 10.1111/aos.12726

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Corneal ectasia associated with postoperative hypotony.

Authors:  Kai B Kang; Elmer Y Tu; Ahmad A Aref; Jacob T Wilensky; Thasarat S Vajaranant
Journal:  Can J Ophthalmol       Date:  2018-06-05       Impact factor: 1.882

2.  Corneal hysteresis and anterior segment optical coherence tomography anatomical parameters in primary angle closure suspects.

Authors:  Syed Amal Hussnain; Kyle D Kovacs; Joshua L Warren; Christopher C Teng
Journal:  Clin Exp Ophthalmol       Date:  2018-01-11       Impact factor: 4.207

3.  Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure.

Authors:  Bianca N Susanna; Nara G Ogata; Alessandro A Jammal; Carolina N Susanna; Samuel I Berchuck; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2019-08-09       Impact factor: 12.079

4.  Repeatability of Corneal Hysteresis Measurements in Glaucoma Patients During Routine Follow Up and After Cataract Surgery.

Authors:  Tzukit Zehavi-Dorin; Anne E Kutzscher; Mai Badr; Marta Mora; Yennie Shyu; Travis C Porco; Robert L Stamper
Journal:  J Glaucoma       Date:  2022-03-01       Impact factor: 2.290

5.  Analyzing biomechanical parameters of the cornea with glaucoma severity in open-angle glaucoma.

Authors:  Karin R Pillunat; Cosima Hermann; Eberhard Spoerl; Lutz E Pillunat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-27       Impact factor: 3.117

6.  The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma.

Authors:  Roman Meda; Qianqian Wang; David Paoloni; Paul Harasymowycz; Isabelle Brunette
Journal:  Br J Ophthalmol       Date:  2016-05-09       Impact factor: 4.638

7.  The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST.

Authors:  Na Wu; Yuhong Chen; Yaping Yang; Xinghuai Sun
Journal:  BMC Ophthalmol       Date:  2020-10-20       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.